drugset / Trial / NCT04684589

Effect of PDE5 Inhibition on Adipose Metabolism in Humans

NCT04684589

Phase 2 Completed 89 enrolled Vanderbilt University Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, double-blinded, placebo-controlled study of the effects of PDE5 inhibition with tadalafil on adipose tissue in obese individuals. Adipose metabolism will be measured using magnetic resonance imaging (MRI) scans and by aspirating a small amount of adipose to measure gene expression.

Timeline

Start
2021-03-16
Primary completion
2025-06-20
Completion
2025-06-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 20 mg Oral

Indications